Drug Trial Radar · NCT06760182
Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis
Last checked: Nov 20, 2026Latest source record: Aug 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
169
Actual
Start
Mar 10, 2025
Primary completion
Apr 30, 2025
Study completion Jul 1, 2025
Sponsor
- Lead sponsor
- Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jan 6, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate TQH2722 injection in all patients receiving background treatment with mometasone furoate nasal spray (MFNS) and loratadine. The efficacy, safety and immunogenicity of the solution in patients with seasonal allergic rhinitis compared with placebo are expected to include 168 patients with confirmed seasonal allergic rhinitis (SAR) who have failed to respond to standard treatments.
Conditions
- Seasonal Allergic Rhinitis
Interventions
TQH2722 injectionDrug
TQH2722 injection is a humanized monoclonal antibody targeting interleukin-4 receptor alpha (IL-4Rα).
TQH2722 PlaceboDrug
Placebo without drug substance.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Retrospective nasal symptom score after treatment for 2 weeksTime frame: Baseline up to 2 weeks
Locations
30 sites in 1 country. Site status is shown where the registry gives one.
Peking University First Hospital
Beijing, Beijing Municipality, China
Peking University People's Hospital
Beijing, Beijing Municipality, China
Peking University Third Hospital
Beijing, Beijing Municipality, China
Gansu Provincial Hospital
Lanzhou, Gansu, China
Cangzhou Central Hospital
Cangzhou, Hebei, China
Hebei Medical University Third Hospital
Shijiazhuang, Hebei, China
Henan Provincial People's Hospital
Zhengzhou, Henan, China
The Central Hospital of Wuhan
Wuhan, Hubei, China
Union Hospital, Tongji Medical College, Huazhong University of science and technology
Wuhan, Hubei, China
Tongji Hospital of Tongji medical college of HUST
Wuhan, Hubei, China
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
Baotou Central Hospital
Baotou, Inner Mongolia, China
Chifeng Municipal Hospital
Chifeng, Inner Mongolia, China
The Affiliated Hospital of Inner Mongolia Medical University
Hohhot, Inner Mongolia, China
Ansteel Group General hospital
Anshan, Liaoning, China
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
Liaoning Health Industry Group Iron Coal General Hospital
Tieling, Liaoning, China
The First People's Hospital of Yinchuan
Yinchuan, Ningxia, China
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
Shandong Second Provincial General Hospital
Jinan, Shandong, China
Qilu Hospital of Shandong University
Qilu, Shandong, China
Yantai Yuhuangding Hospital
Yantai, Shandong, China
Zibo Central Hospital
Zibo, Shandong, China
Shanxi Bethune Hospital
Taiyuan, Shanxi, China
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China
Tianjin People's Hospital
Tianjin, Tianjin Municipality, China
Tianjin First Central Hospital
Tianjin, Tianjin Municipality, China
The First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China
The First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.